drugset / Trial / NCT06493409
A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of coadministration of voriconazole or quinidine on the pharmacokinetics (PK) of repotrectinib in healthy male and female (individual not of childbearing potential \[INOCBP\]) participants.
Timeline
- Start
- 2024-08-26
- Primary completion
- 2024-12-07
- Completion
- 2024-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quinidine | Small molecule | — | — |
| Subject | Repotrectinib | Small molecule | — | — |
| Subject | Voriconazole | Small molecule | — | — |
Indications
No indication recorded.